Surrozen (SRZN) Non Operating Income (2020 - 2026)

Surrozen (SRZN) recorded quarterly Non Operating Income of -$41.1 million in Q1 2026, up 31.02% quarter-over-quarter from -$59.6 million in Q4 2025, and down 208.22% on a YoY basis from $38.0 million in Q1 2025.

Surrozen (SRZN) Non Operating Income (2020 - 2026) Analysis & Trends

Surrozen's Non Operating Income history runs 7 years deep, the most recent figure standing at -$41.1 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 208.22% year-over-year to -$41.1 million; the TTM figure through Mar 2026 stood at -$105.4 million (down 662.18% YoY), while the FY2025 annual figure was -$26.3 million, down 36.18% from the prior year.
  • Non Operating Income was -$41.1 million for Q1 2026 at Surrozen, up from -$59.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $38.0 million in Q1 2025 to a low of -$59.6 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$4.6 million across 5 years, with a median of $83000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income jumped 92100.0% in 2022, then sank 6667.55% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $920000.0 in 2022, then slumped by 67.17% to $302000.0 in 2023, then tumbled by 6667.55% to -$19.8 million in 2024, then sank by 200.46% to -$59.6 million in 2025, then soared by 31.02% to -$41.1 million in 2026.
  • The last three Non Operating Income figures came in at -$41.1 million (Q1 2026), -$59.6 million (Q4 2025), and -$20.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 5.75 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 444,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - 9.35 Mn
10 Surrozen 225,877.86 -106.68 Mn - -41.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.11 Mn
Dec 31, 2025 -59.59 Mn
Sep 30, 2025 -20.92 Mn
Jun 30, 2025 16.22 Mn
Mar 31, 2025 37.99 Mn
Dec 31, 2024 -19.83 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 3.70 Mn
Mar 31, 2024 -85,000.00
Dec 31, 2023 302,000.00
Sep 30, 2023 83,000.00
Jun 30, 2023 265,000.00
Mar 31, 2023 -252,000.00
Dec 31, 2022 920,000.00
Sep 30, 2022 50,000.00
Jun 30, 2022 87,000.00
Mar 31, 2022 6.50 Mn
Dec 31, 2021 -1,000.00
Sep 30, 2021 -328,000.00
Dec 31, 2020 -1.68 Mn